CN102600438A - Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease - Google Patents
Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease Download PDFInfo
- Publication number
- CN102600438A CN102600438A CN2012101188023A CN201210118802A CN102600438A CN 102600438 A CN102600438 A CN 102600438A CN 2012101188023 A CN2012101188023 A CN 2012101188023A CN 201210118802 A CN201210118802 A CN 201210118802A CN 102600438 A CN102600438 A CN 102600438A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- hyperlipidemia
- root
- hypertension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000031226 Hyperlipidaemia Diseases 0.000 title claims abstract description 26
- 239000003814 drug Substances 0.000 title claims abstract description 14
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 13
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 11
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 11
- 235000004879 dioscorea Nutrition 0.000 claims abstract description 3
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 239000008517 radix Trichosanthis Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241000514744 Cyclina Species 0.000 claims description 2
- 235000005903 Dioscorea Nutrition 0.000 claims description 2
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 2
- 244000281702 Dioscorea villosa Species 0.000 claims description 2
- 241000510609 Ferula Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000110637 Cuscuta chinensis Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 235000007162 Ferula assa foetida Nutrition 0.000 abstract 1
- 244000228957 Ferula foetida Species 0.000 abstract 1
- 235000012850 Ferula foetida Nutrition 0.000 abstract 1
- 241001540526 Leptonotus elevatus Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 241000218989 Trichosanthes Species 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 208000020346 hyperlipoproteinemia Diseases 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000000378 dietary effect Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 208000019423 liver disease Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 102000007592 Apolipoproteins Human genes 0.000 description 1
- 108010071619 Apolipoproteins Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000014311 Cushing syndrome Diseases 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102000011965 Lipoprotein Receptors Human genes 0.000 description 1
- 108010061306 Lipoprotein Receptors Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000007345 glycogen storage disease Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000008604 lipoprotein metabolism Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 201000009395 primary hyperaldosteronism Diseases 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease. The medicament comprises the following components in parts by weight: 30 parts of dried rehmannia root, 10 parts of radix ophiopogonis, 20 parts of root of Chinese trichosanthes, 30 parts of root of kudzu vine, 10 parts of epimedium, 30 parts of astragalus root, 20 parts of yams, 25 parts of root of bidentate achyranthes, 15 parts of uncaria, 15 parts of sea clam shells, 10 parts of asafetida, 10 parts of pipe fish, 25 parts of polygonum multiflorum, 10 parts of parasitic loranthus, 10 parts of radix curcumae, 20 parts of root of red-rooted salvia, 10 parts of pericarpium trichosanthis, 15 parts of seed of Chinese dodder and 15 parts of Szechuan lovage rhizome.
Description
Technical field
The present invention relates to a kind of medicine of treating diabetes, hypertension, hyperlipidemia and coronary heart disease.
Background technology
Diabetes are to act on that body causes hypoinsulinism, insulin resistant etc. and a series of metabolism disorder syndromes such as the sugar that causes, protein, fat, power and water Xie Zhi by inherited genetic factors, immunologic function disorder, infected by microbes and toxin thereof, free radical toxin, Nervous and Mental Factors or the like various virulence factors; Be main feature clinically with the hyperglycemia; Performance such as polyuria, polydipsia, polyphagia can appear in model case, become thin; I.e. " three-many-one-little " symptom; Diabetes (blood glucose) cause complication in case control bad meeting, cause the depleted pathological changes at positions such as kidney, eye, foot, and can't cure.
Hypertension (hypertensive disease) is a kind of chronic disease that serves as main performance with the lasting rising of arteriotony, often causes the pathological changes of vitals such as the heart, brain, kidney and corresponding consequence occurs.Lipid metabolism or running make one or more lipids of blood plasma be higher than normally to be called hyperlipidemia unusually.Hyperlipidemia is a kind of systemic disease, refers to that T-CHOL in the blood (TC) and/or triglyceride (TG) are too high or HDL-C (HDL-C) is low excessively, and modern medicine is referred to as dyslipidemia.Lipid is insoluble or be slightly soluble in water, must exist with the lipoprotein form with protein bound, and therefore, hyperlipidemia is also referred to as hyperlipoproteinemia usually.The cause of disease of hyperlipidemia can be divided into two big types, i.e. constitutional hyperlipidemia and Secondary cases hyperlipidemia basically.
The constitutional hyperlipidemia
1, inherited genetic factors.Heredity can cause hyperlipemia through number of mechanisms; Some possibly occur on the cellular level; Mainly show as the defective (like the defective or the shortage of lipoprotein lipase) of some enzyme in cell surface lipoprotein receptor volume defect and the cell; Also can occur on the molecule of lipoprotein or apolipoprotein, many owing to genetic flaw causes.
2, dietary factor.Dietary factor effect more complicated, it is closely-related with dietary factor during hyperlipoproteinemia patient is in hospital sizable ratio being arranged.
3, clinical experiment shows: the normocyte in the blood, colloid particle etc. are electronegative, repel each other between them, keep certain distance; And the aged erythrocyte of pathological changes is fought for owing to electronics; Positively charged, because positive negative suction, then that red blood cell condensation is agglomerating causes hyperlipidemia.
The Secondary cases hyperlipidemia
The Secondary cases hyperlipidemia is that these diseases comprise: diabetes, hepatopathy, thyroid disease, kidney disease, pancreas, obesity, glycogen storage disease, gout, bronzed disease, Cushing's syndrome, abnormal globulin mass formed by blood stasis etc. owing to primary disease institute causer in the middle of other.
1, diabetes and hyperlipoproteinemia.Close getting in touch arranged between carbohydrate metabolism and the lipid metabolism in human body, and clinical research is found, but about 40% diabetics secondary causes hyperlipemia.
2, hepatopathy and hyperlipoproteinemia.The modern medicine study data confirms that many materials comprise that lipid and lipoprotein etc. are to process, produce at liver and decomposition, excretory.In case liver has pathological changes, then lipid and lipoprotein metabolism also will get muddled.
3, obesity and hyperlipoproteinemia.Local clinic study data shows, the Chang Jifa of obesity causes that blood triglyceride content increases, and part patient at first cholesterolemia content also may increase, and mainly shows as iv type hyperlipoproteinemia mostly, is iib type hyperlipoproteinemia secondly.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of treating diabetes, hypertension, hyperlipidemia and coronary heart disease.
The present invention is made up of following components by part by weight:
30 parts of Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Radix Trichosanthis, 30 parts of Radix Puerariaes, 15 parts of Herba Epimedii; 30 parts of Radix Astragali, 20 parts of Rhizoma Dioscoreaes, 25 parts of Radix Achyranthis Bidentataes, 15 parts of Ramulus Uncariae Cum Uncis, 15 parts of Concha Meretricis seu Cyclinaes; 10 parts of Resina Ferulaes, 10 parts of Solenognathus, 25 parts of Radix Polygoni Multiflori, 10 parts of Herba Taxillis, 10 parts of Radix Curcumaes; 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pericarpium Trichosanthiss, 15 parts of Semen Cuscutae, 15 parts of Rhizoma Chuanxiongs.
The present invention is with Radix Rehmanniae, Radix Ophiopogonis, Radix Trichosanthis, Radix Puerariae, Herba Epimedii invigorating the spleen and replenishing QI, YIN nourishing and the production of body fluid promoting, the yang invigorating of quenching one's thirst; With Radix Astragali, Rhizoma Dioscoreae invigorating the spleen and benefiting QI; With Radix Achyranthis Bidentatae, Ramulus Uncariae Cum Uncis, Concha Meretricis seu Cyclinae, Resina Ferulae, the steady blood pressure of Solenognathus; With Radix Polygoni Multiflori, Herba Taxilli and Radix Curcumae purify the blood fat melting and thrombolytic; With the multiple arteries and veins of Radix Salviae Miltiorrhizae, Pericarpium Trichosanthis, Semen Cuscutae and Rhizoma Chuanxiong collateral dredging, kidney nourishing water is contained edema with the liver involved, and heart-fire falls in strengthening the spleen soil, except that scorching, and Ji blood.
Beneficial effect of the present invention:
The present invention has invigorating the spleen and replenishing QI, YIN nourishing removing heat from blood, moisturizes, tonifying the kidney to consolidate the essence, promoting the production of body fluid to quench thirst, eliminating phlegm to promote tissue regeneration, supplementing QI and nourishing YIN, blood circulation promoting and blood stasis dispelling, multiple arteries and veins, blood nourishing acupuncture-stimulating, invigorating the spleen and benefiting QI, clearing away heat-damp and promoting diuresis and consolidate the effect of setting upright nourish heart.Effect with treatment diabetes, hypertension, hyperlipidemia and coronary heart disease.
The specific embodiment
Present embodiment is made up of following components by part by weight:
Radix Rehmanniae 30g, Radix Ophiopogonis 10g, Radix Trichosanthis 20g, Radix Puerariae 30g, Herba Epimedii 15g, Radix Astragali 30g, Rhizoma Dioscoreae 20g; Radix Achyranthis Bidentatae 25g, Ramulus Uncariae Cum Uncis 15g, Concha Meretricis seu Cyclinae 15g, Resina Ferulae 10g, Solenognathus 10g, Radix Polygoni Multiflori 25g; Herba Taxilli 10g, Radix Curcumae 10g, Radix Salviae Miltiorrhizae 20g, Pericarpium Trichosanthis 10g, Semen Cuscutae 15g, Rhizoma Chuanxiong 15g.Process decoction according to above-mentioned prescription, every milliliter contains crude drug 1g, every day 3 times, obeys 50～80ml at every turn.
Treatment diabetes case: Liu, woman, 53 years old.Suffered from diabetes 3 years, a clothes insoral.The empty stomach glucose in urine (+++), blood glucose 238mg/dl (13.3mmol/L), food back blood glucose 327mg/dl (18.2mmol/L).Thirsty polydipsia, the urine amount is many, the soreness of waist, spirit is tired, and big dry stool is dizzy nervous, is prone to perspire, and is very scorching, deficiency in origin and excess in superficiality.Take the present invention's medicine 35 days, thirstyly end, glucose in urine is normal, and spirit takes a turn for the better.
Treatment hypertension, hyperlipidemia and coronary heart disease case: Zhang, the man, 65 years old, suffer from hypertension, hyperlipidemia and coronary heart disease simultaneously, clothes Western medicine blood pressure lowering lacks the greasy food blood fat reducing of edible oil, and then avoids the outbreak of coronary heart disease, and clothes Western medicine blood pressure lowering has formed dependency.These clothes the present invention's medicine is after March, and blood pressure is basicly stable in normal range, and blood fat obviously reduces, and coronary heart disease was not shown effect within 1 year.
Claims (1)
1. medicine of treating diabetes, hypertension, hyperlipidemia and coronary heart disease, form by following components by part by weight:
30 parts of Radix Rehmanniae, 10 parts of Radix Ophiopogonis, 20 parts of Radix Trichosanthis, 30 parts of Radix Puerariaes, 15 parts of Herba Epimedii; 30 parts of Radix Astragali, 20 parts of Rhizoma Dioscoreaes, 25 parts of Radix Achyranthis Bidentataes, 15 parts of Ramulus Uncariae Cum Uncis, 15 parts of Concha Meretricis seu Cyclinaes; 10 parts of Resina Ferulaes, 10 parts of Solenognathus, 25 parts of Radix Polygoni Multiflori, 10 parts of Herba Taxillis, 10 parts of Radix Curcumaes; 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Pericarpium Trichosanthiss, 15 parts of Semen Cuscutae, 15 parts of Rhizoma Chuanxiongs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210118802.3A CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210118802.3A CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600438A true CN102600438A (en) | 2012-07-25 |
| CN102600438B CN102600438B (en) | 2014-04-23 |
Family
ID=46518457
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210118802.3A Active CN102600438B (en) | 2012-04-21 | 2012-04-21 | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600438B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103721187A (en) * | 2013-12-20 | 2014-04-16 | 安徽金太阳生化药业有限公司 | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill |
| CN104547959A (en) * | 2015-02-09 | 2015-04-29 | 王士国 | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof |
| CN104922505A (en) * | 2015-05-31 | 2015-09-23 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with hypertension and hyperlipidemia |
| CN106074980A (en) * | 2016-07-29 | 2016-11-09 | 任立群 | A kind of blood fat reducing healthcare food |
| CN106389777A (en) * | 2016-11-29 | 2017-02-15 | 汪承武 | Traditional Chinese medicine for treating diabetes accompanied by hyperlipidemia and preparation method |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088450A (en) * | 1993-01-01 | 1994-06-29 | 淄博市淄川区第二制药厂 | The excellent blood fat reducing of preparation of treatment hyperlipidemia |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1442190A (en) * | 2003-04-01 | 2003-09-17 | 四川省中医药研究院中医研究所 | Chinese medicine possessing kidney supplementing brain fortifying, statis transforming and vessel freeing actions |
| CN1443544A (en) * | 2002-03-07 | 2003-09-24 | 张世均 | Chinese medicine Jiangtang Tongmailing for curing diabetes and preventing and curing complicating diseases and its preparation method |
| CN1555817A (en) * | 2003-12-30 | 2004-12-22 | 王胜霞 | Medicine ginseng and astragalus yam paste for treating diabates and its preparation method |
| JP2005325107A (en) * | 2004-04-15 | 2005-11-24 | Taisho Pharmaceut Co Ltd | Regulator of feminine hormone balance |
| CN1970069A (en) * | 2006-12-26 | 2007-05-30 | 曹国胜 | Chinese medicinal pill for treating coronary heart disease |
| CN102178786A (en) * | 2011-05-04 | 2011-09-14 | 重庆康刻尔制药有限公司 | Medicament combination for treating diabetic peripheral neuropathy as well as preparation method and application thereof |
| CN102397459A (en) * | 2011-10-19 | 2012-04-04 | 李顺光 | Traditional Chinese medicine for treating diabetes and preparation method thereof |
-
2012
- 2012-04-21 CN CN201210118802.3A patent/CN102600438B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088450A (en) * | 1993-01-01 | 1994-06-29 | 淄博市淄川区第二制药厂 | The excellent blood fat reducing of preparation of treatment hyperlipidemia |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1443544A (en) * | 2002-03-07 | 2003-09-24 | 张世均 | Chinese medicine Jiangtang Tongmailing for curing diabetes and preventing and curing complicating diseases and its preparation method |
| CN1442190A (en) * | 2003-04-01 | 2003-09-17 | 四川省中医药研究院中医研究所 | Chinese medicine possessing kidney supplementing brain fortifying, statis transforming and vessel freeing actions |
| CN1555817A (en) * | 2003-12-30 | 2004-12-22 | 王胜霞 | Medicine ginseng and astragalus yam paste for treating diabates and its preparation method |
| JP2005325107A (en) * | 2004-04-15 | 2005-11-24 | Taisho Pharmaceut Co Ltd | Regulator of feminine hormone balance |
| CN1970069A (en) * | 2006-12-26 | 2007-05-30 | 曹国胜 | Chinese medicinal pill for treating coronary heart disease |
| CN102178786A (en) * | 2011-05-04 | 2011-09-14 | 重庆康刻尔制药有限公司 | Medicament combination for treating diabetic peripheral neuropathy as well as preparation method and application thereof |
| CN102397459A (en) * | 2011-10-19 | 2012-04-04 | 李顺光 | Traditional Chinese medicine for treating diabetes and preparation method thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103721187A (en) * | 2013-12-20 | 2014-04-16 | 安徽金太阳生化药业有限公司 | Blood-circulation-promoting and blood-fat-reducing pill for treating hyperlipemia and preparation method of pill |
| CN104547959A (en) * | 2015-02-09 | 2015-04-29 | 王士国 | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof |
| CN104922505A (en) * | 2015-05-31 | 2015-09-23 | 济南邦文医药科技有限公司 | Traditional Chinese medicine for treating coronary heart disease stable angina pectoris complicated with hypertension and hyperlipidemia |
| CN106074980A (en) * | 2016-07-29 | 2016-11-09 | 任立群 | A kind of blood fat reducing healthcare food |
| CN106389777A (en) * | 2016-11-29 | 2017-02-15 | 汪承武 | Traditional Chinese medicine for treating diabetes accompanied by hyperlipidemia and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600438B (en) | 2014-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102600438B (en) | Medicament for treating diabetes mellitus, hypertension, hyperlipidemia and coronary heart disease | |
| CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
| CN103040960A (en) | Traditional Chinese medicine formula for treating high blood pressure | |
| CN101766783A (en) | Traditional Chinese medicine combination for treating cholecystitis and capsule preparation method thereof | |
| CN103933220A (en) | Medicine for treating climacteric syndrome | |
| CN103768191A (en) | Traditional Chinese medicinal mixture for preventing fatty liver and preparation method and application thereof | |
| CN103006989B (en) | Medical composition for treating diabetic nephropathy | |
| CN102526611A (en) | Chinese medicinal composition for treating chronic heart failure | |
| CN110339320B (en) | Traditional Chinese medicine composition for treating fatty liver | |
| CN102429977B (en) | Medicine for treating diabetes | |
| CN104208420A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN101073660A (en) | Chinese-medicinal composition for treating chronic hepatitis B and its production | |
| CN103142844A (en) | Pharmaceutical composition for treating diabetic nephropathy | |
| CN103417694A (en) | Traditional Chinese medicine used for treating diabetes | |
| CN101549045B (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN102764366A (en) | Traditional Chinese medicine for treating chronic lymphatic thyroiditis | |
| CN101766768A (en) | Traditional Chinese medicine granule for treating allergic rhinitis | |
| CN101961420A (en) | Traditional Chinese medicine for treating diabetic nephropathy | |
| CN104524156A (en) | Traditional Chinese medicine cataplasma for treating autoimmune thyroiditis | |
| CN103330836A (en) | Traditional Chinese medicine composition for treating diabetes mellitus, and application of traditional Chinese medicine composition | |
| CN104000938A (en) | Traditional Chinese medicine composition for treating IgA nephropathy and application thereof | |
| CN103893498B (en) | A kind of blood sugar lowering extract and feedstock composition and preparation method thereof, purposes | |
| CN103463358A (en) | Traditional Chinese medicine compound preparation for treatment of diabetes and preparation method thereof | |
| CN101953956A (en) | Traditional Chinese medicine for treating diabetic nephropathy | |
| CN103566279A (en) | Medicine for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210204 Address after: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee after: Han Hexu Patentee after: Yi Gangqiao Address before: Room 608, unit 3, building 2, Carnival community, Luyuan District, Changchun City, Jilin Province Patentee before: Han Hexu |